// App-Quantinova.ai

2102-300 : BAYESIAN META-ANALYSIS IDENTIFIES THE INTERVENTIONAL ADVANCES RESPONSIBLE FOR THE DIMINISHED BLEEDING ADVANTAGE OF BIVALIRUDIN OVER HEPARIN

Researchers

Presenter

  • John A. Bittl

Principal Investigators

  • N/A

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Bivalirudin

  • Hemostatic Solution

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved